机构：[1]Department of Respiratory Medicine, Fujian Medical University Union Hospital, Fuzhou, Fujian350000, China.[2]Department of Geriatrics, Fujian Medical University Union Hospital, Fuzhou, Fujian350000, China.[3]Hongqiao International Institute of Medicine, Shanghai Tongren Hospital/Clinical Research Institute, Shanghai Jiao Tong University School of Medicine, Shanghai200025, China.[4]Department of Oncology, Fujian Medical University Union Hospital, Fuzhou, Fujian350000, China.[5]Fujian Key Laboratory of Translational Research in Cancer and Neurodegenerative Diseases, Fuzhou, Fujian350122, China.
Joint Funds for the
Innovation of Science and Technology, Fujian Province,
China (Nos. 2016Y9028, 2019Y9055 and 2020Y9090),
Fujian provincial health technology project (No.
2020CXB016) and the Natural Science Foundation of
Fujian Province (No. 2021J01772).
第一作者机构：[1]Department of Respiratory Medicine, Fujian Medical University Union Hospital, Fuzhou, Fujian350000, China.[2]Department of Geriatrics, Fujian Medical University Union Hospital, Fuzhou, Fujian350000, China.
通讯作者：
通讯机构：[1]Department of Respiratory Medicine, Fujian Medical University Union Hospital, Fuzhou, Fujian350000, China.[2]Department of Geriatrics, Fujian Medical University Union Hospital, Fuzhou, Fujian350000, China.[5]Fujian Key Laboratory of Translational Research in Cancer and Neurodegenerative Diseases, Fuzhou, Fujian350122, China.[*1]Department of Respiratory Medicine, Fujian Medi‐ cal University Union Hospital, No. 29 Xinquan Road, Gulou District, Fuzhou, Fujian 350000, China
推荐引用方式(GB/T 7714)：
Xue Dan,Zhu Tengteng,Lin Hongguang,et al.Transcriptome dysregulation in hyper-progressive disease samples with immune checkpoint blockade[J].CHINESE MEDICAL JOURNAL.2023,136(24):3019-3021.doi:10.1097/CM9.0000000000002550.
APA：
Xue Dan,Zhu Tengteng,Lin Hongguang,Guo Peilin,Li Mengling...&Chen Xiangqi.(2023).Transcriptome dysregulation in hyper-progressive disease samples with immune checkpoint blockade.CHINESE MEDICAL JOURNAL,136,(24)
MLA：
Xue Dan,et al."Transcriptome dysregulation in hyper-progressive disease samples with immune checkpoint blockade".CHINESE MEDICAL JOURNAL 136..24(2023):3019-3021
